SCEMBLIX 100 mg/1 (Asciminib TABLET, FILM COATED) 100 mg/1

SCEMBLIX 100 mg is a medication containing asciminib, used for targeted therapy. This oral tablet is designed for specific medical conditions and is manufactured by Novartis Pharmaceuticals Corporation.

Strength

100 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0078-1196-20)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SCEMBLIX 100 mg is primarily used in the management of certain types of chronic myeloid leukemia (CML). This medication works by targeting specific proteins involved in the growth of cancer cells. Patients often wonder, 'What is SCEMBLIX used for?' It is typically prescribed for adults with CML who have developed resistance or intolerance to other treatments.

Side Effects

Common effects of SCEMBLIX 100 mg may include fatigue, nausea, and muscle pain. Some individuals might experience changes in blood cell counts or liver function. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

SCEMBLIX 100 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients should avoid crushing or breaking the tablets. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Avoid Interactions

SCEMBLIX 100 mg may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Alcohol consumption should be discussed with a healthcare professional to avoid potential interactions.

Frequently Asked Questions

SCEMBLIX 100 mg is used for the treatment of certain types of chronic myeloid leukemia (CML) in adults.

SCEMBLIX 100 mg should be taken orally, typically once daily, with or without food. Follow your healthcare provider's instructions for the best results.

Common side effects may include fatigue, nausea, muscle pain, and changes in blood cell counts. Always consult your healthcare provider if you experience severe or persistent effects.

SCEMBLIX 100 mg may interact with certain medications. Inform your healthcare provider about all medications you are taking to avoid potential interactions.

The safety of SCEMBLIX 100 mg during pregnancy has not been established. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.